Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
380.17
-7.47 (-1.93%)
Jul 30, 2026, 10:38 AM EDT - Market open
Amgen Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 37,220 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
Revenue Growth | 9.07% | 9.95% | 18.57% | 7.09% | 1.32% | 2.18% |
Gross Profit Gross Profit Growth | 25,407 | 24,714 | 20,566 | 19,739 | 19,917 | 19,525 |
Operating Income Operating Income Growth | 10,568 | 9,080 | 7,258 | 7,897 | 9,566 | 7,639 |
Net Income Net Income Growth | 7,800 | 7,711 | 4,090 | 6,717 | 6,552 | 5,893 |
Earnings Per Share EPS Growth | 14.37 | 14.23 | 7.56 | 12.49 | 12.11 | 10.28 |
EPS Growth | 31.11% | 88.23% | -39.47% | 3.14% | 17.80% | -16.49% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Prolia Prolia Growth | 4,042 | 4,414 | 4,374 | 4,048 | 3,628 | 3,248 |
ENBREL ENBREL Growth | 2,036 | 2,226 | 3,316 | 3,697 | 4,117 | 4,465 |
XGEVA XGEVA Growth | 1,929 | 2,084 | 2,225 | 2,112 | 2,014 | 2,018 |
Repatha Repatha Growth | 3,236 | 3,016 | 2,222 | 1,635 | 1,296 | 1,117 |
Otezla Otezla Growth | 2,259 | 2,265 | 2,126 | 2,188 | 2,288 | 2,249 |
TEPEZZA TEPEZZA Growth | 2,012 | 1,903 | 1,851 | 448 | - | - |
EVENITY EVENITY Growth | 2,220 | 2,100 | 1,563 | 1,160 | 787 | 530 |
KYPROLIS KYPROLIS Growth | 1,418 | 1,412 | 1,503 | 1,403 | 1,247 | 1,108 |
Nplate Nplate Growth | 1,623 | 1,524 | 1,456 | 1,477 | 1,307 | 1,027 |
Aranesp Aranesp Growth | 1,360 | 1,389 | 1,342 | 1,362 | 1,421 | 1,480 |
BLINCYTO BLINCYTO Growth | 1,604 | 1,559 | 1,216 | 861 | 583 | 472 |
KRYSTEXXA KRYSTEXXA Growth | 1,359 | 1,340 | 1,185 | 272 | - | - |
Vectibix Vectibix Growth | 1,195 | 1,175 | 1,045 | 984 | 893 | 873 |
TEZSPIRE TEZSPIRE Growth | 1,536 | 1,478 | 972 | 567 | 170 | - |
Other Products Other Products Growth | 7,664 | 7,263 | 5,630 | 4,696 | 5,050 | 5,710 |
Other Other Growth | 1,727 | 1,603 | 1,398 | 1,280 | 1,522 | 1,682 |
Revenue (Total) Revenue (Total) Growth | 37,220 | 36,751 | 33,424 | 28,190 | 26,323 | 25,979 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 12,038 | 9,129 | 11,973 | 10,944 | 9,305 | 8,037 |
Total Debt Total Debt Growth | 57,323 | 54,604 | 60,099 | 64,613 | 38,945 | 33,309 |
Net Cash (Debt) Net Cash Growth | -45,285 | -45,475 | -48,126 | -53,669 | -29,640 | -25,272 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -83.47 | -83.90 | -88.96 | -99.76 | -54.79 | -44.10 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 10,756 | 9,958 | 11,490 | 8,471 | 9,721 | 9,261 |
Capital Expenditures CapEx Growth | -2,159 | -1,858 | -1,096 | -1,112 | -936 | -880 |
Free Cash Flow Free Cash Flow Growth | 8,597 | 8,100 | 10,394 | 7,359 | 8,785 | 8,381 |
Free Cash Flow Growth | -21.24% | -22.07% | 41.24% | -16.23% | 4.82% | -15.25% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 68.26% | 67.25% | 61.53% | 70.02% | 75.66% | 75.16% |
Operating Margin | 28.39% | 24.71% | 21.71% | 28.01% | 36.34% | 29.40% |
Pretax Margin | 24.41% | 24.42% | 13.79% | 27.86% | 27.91% | 25.79% |
Profit Margin | 20.96% | 20.98% | 12.24% | 23.83% | 24.89% | 22.68% |
FCF Margin | 23.10% | 22.04% | 31.10% | 26.11% | 33.37% | 32.26% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 10.080 | 9.520 | 9.000 | 8.520 | 7.760 | 7.040 |
Dividend Per Share Growth | 5.83% | 5.78% | 5.63% | 9.79% | 10.23% | 10.00% |
Dividend Yield | 2.64% | 2.91% | 3.45% | 2.96% | 2.97% | 3.13% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 26.98 | 23.00 | 34.48 | 23.06 | 21.69 | 21.88 |
Forward PE | 17.17 | 15.46 | 12.59 | 14.95 | 14.40 | 13.06 |
P/FCF Ratio | 24.34 | 21.77 | 13.46 | 20.95 | 15.96 | 14.99 |
PS Ratio | 5.62 | 4.80 | 4.19 | 5.47 | 5.33 | 4.83 |